FDA inspection
Baxter Pharmaceuticals India Pvt Ltd: FDA inspection ending Jan 27, 2023
FDA inspection 1195842 · Official Action Indicated (OAI) · Ahmedabad
Key facts
| Inspection ID | 1195842 |
|---|---|
| Firm | Baxter Pharmaceuticals India Pvt Ltd |
| FEI number | 3004610460 |
| Address | Village Vasana Chacharwadi, Taluka Sanand |
| City | Ahmedabad |
| Country | India |
| Fiscal year | 2023 |
| Inspection end date | Jan 27, 2023 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 654136 |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data